Sanket Koul

Macron announced plans to triple the number of Indian students in France and launched an Indo-French AI health centre, as both nations deepen cooperation in AI, mobility and nuclear R&D

Central Park will invest ₹1,200 crore in its new ultra-luxury Belanova project in Gurugram, targeting sales of up to ₹3,000 crore with phased pricing and strong early demand

AIOCD has urged the Prime Minister to ban AI-generated prescriptions, alleging they are being misused by unregulated e-pharmacies to sell restricted medicines, posing a serious public health risk

India's five listed REITs distributed over Rs 2,450 crore to 380,000 unitholders in Q3 FY26, backed by strong leasing momentum, improving occupancies and regulatory moves expanding access to capital

The pharmaceuticals department has invited stakeholder comments on proposed changes to the list of 350-plus medical devices exempt from GTE rules, with submissions open until February

Homes priced above ₹3 crore saw a 58% rise in lead-to-buy conversion time in 2025 as buyers became more selective, even as overall housing conversion time fell 18% due to faster big-ticket purchases

The steady migration of affluent households from other parts of Delhi towards South Delhi, driven by its superior social infrastructure, iconic value and lifestyle offering, has boosted demand

Board gives in-principle nod to make Biocon Biologics a wholly owned subsidiary as Q3 net profit climbs to Rs 143.8 crore

Joint centre, initiated by Union Education Ministry, will build scalable, human-centric AI systems for manufacturing sectors including semiconductors and robotics

Education Minister Dharmendra Pradhan chairs AI roundtable with edtech founders ahead of launch of IIT Madras-anchored Bharat Bodhan AI Foundation

Health Ministry proposes removing provisional registration for ethics committees, shifting to single-stage approval to streamline clinical research and cut regulatory delays

Industry executives say the US-Bangladesh reciprocal trade agreement is unlikely to materially affect India's pharma and medtech exports, given India's scale and established FDA-approved supply chains

CBSE has announced the introduction of on-screen marking for Class 12 board exams from February 17, aiming to improve efficiency, transparency and reduce time and logistical costs

IHH Healthcare and Fortis Healthcare have launched IHH Catalyst, a national platform to help execution-ready medtech and healthtech startups move from pilots to hospital adoption and scale

Revised FAR/FSI limits, height relaxations lead to increased investor interest

Domestic device makers warn of safety and dumping risks, while MNC bodies back affordability benefits as the Centre reviews policy on refurbished high-end medical device imports

Pharma-focused Budget 2026 measures could help India move beyond generics by boosting biologics, biosimilars, regulatory capacity and early-stage innovation, analysts say

Just 102 of the 297 day care cancer centres approved for FY26 are operational so far, with states such as Telangana, Bihar and Karnataka reporting a higher share of functional facilities

Doctors also point to declining professional dignity, workplace violence and medico-legal vulnerability as deterrents

India's pharmaceutical exports to the US are unlikely to see major tariff changes under the interim pact as Section 232 investigations continue, though medical devices may gain from better access